A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain

NCT01186770 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

804

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid-Induced Constipation

Interventions

DRUG: Methylnaltrexone
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.

Collaborators

[object Object]